Works by Mizuno, Kyoichi

Results: 93
    1
    2

    Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study.

    Published in:
    PLoS ONE, 2022, v. 17, n. 11, p. 1, doi. 10.1371/journal.pone.0277921
    By:
    • Narita, Ichiei;
    • Hayashi, Terumasa;
    • Maruyama, Shoichi;
    • Masaki, Takao;
    • Nangaku, Masaomi;
    • Nishino, Tomoya;
    • Sato, Hiroshi;
    • Sofue, Tadashi;
    • Wada, Takashi;
    • Imai, Enyu;
    • Iwasaki, Manabu;
    • Mizuno, Kyoichi;
    • Hase, Hiroki;
    • Kamouchi, Masahiro;
    • Yamamoto, Hiroyasu;
    • Kagimura, Tatsuo;
    • Tanabe, Kenichiro;
    • Kato, Hideki;
    • Wada, Takehiko;
    • Usui, Tomoko
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10

    SNPs on chromosome 5p15.3 associated with myocardial infarction in Japanese population.

    Published in:
    Journal of Human Genetics, 2011, v. 56, n. 1, p. 47, doi. 10.1038/jhg.2010.141
    By:
    • Aoki, Asako;
    • Ozaki, Kouichi;
    • Sato, Hiroshi;
    • Takahashi, Atsushi;
    • Kubo, Michiaki;
    • Sakata, Yasuhiko;
    • Onouchi, Yoshihiro;
    • Kawaguchi, Takahisa;
    • Lin, Tsung-Hsien;
    • Takano, Hitoshi;
    • Yasutake, Masahiro;
    • Hsu, Po-Chao;
    • Ikegawa, Shiro;
    • Kamatani, Naoyuki;
    • Tsunoda, Tatsuhiko;
    • Juo, Suh-Hang H;
    • Hori, Masatsugu;
    • Komuro, Issei;
    • Mizuno, Kyoichi;
    • Nakamura, Yusuke
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Arachidonic Acid Metabolites in Acute Myocardial Infarction.

    Published in:
    Angiology, 1996, v. 47, n. 7, p. 649, doi. 10.1177/000331979604700703
    By:
    • Takase, Bonpei;
    • Maruyama, Toshiharu;
    • Kurita, Akira;
    • Uehata, Akimi;
    • Nishioka, Toshihiko;
    • Mizuno, Kyoichi;
    • Nakamura, Haruo;
    • Katsura, Kenichiro;
    • Kanda, Yoshikazu
    Publication type:
    Article
    21
    22
    23
    24
    25

    Impact of Prediabetic Status on Coronary Atherosclerosis.

    Published in:
    Diabetes Care, 2013, v. 36, n. 3, p. 729, doi. 10.2337/dc12-1635
    By:
    • KURIHARA, OSAMU;
    • TAKANO, MASAMICHI;
    • YAMAMOTO, MASANORI;
    • SHIRAKABE, AKIHIRO;
    • KIMATA, NAKAHISA;
    • INAMI, TORU;
    • KOBAYASHI, NOBUAKI;
    • MUNAKATA, RYO;
    • MURAKAMI, DAISUKE;
    • INAMI, SHIGENOBU;
    • OKAMATSU, KENTARO;
    • OHBA, TAKAYOSHI;
    • IBUKI, CHIKAO;
    • HATA, NORITAKE;
    • SEINO, YOSHIHIKO;
    • MIZUNO, KYOICHI
    Publication type:
    Article
    26
    27
    28
    29
    30
    31

    Initial responsiveness to darbepoetin alfa and its contributing factors in non-dialysis chronic kidney disease patients in Japan.

    Published in:
    Clinical & Experimental Nephrology, 2021, v. 25, n. 2, p. 110, doi. 10.1007/s10157-020-01969-7
    By:
    • Hayashi, Terumasa;
    • Kato, Hideki;
    • Tanabe, Kenichiro;
    • Nangaku, Masaomi;
    • Hirakata, Hideki;
    • Wada, Takashi;
    • Sato, Hiroshi;
    • Yamazaki, Yasushi;
    • Masaki, Takao;
    • Kagimura, Tatsuo;
    • Yamamoto, Hiroyasu;
    • Hase, Hiroki;
    • Kamouchi, Masahiro;
    • Imai, Enyu;
    • Mizuno, Kyoichi;
    • Iwasaki, Manabu;
    • Akizawa, Tadao;
    • Tsubakihara, Yoshiharu;
    • Maruyama, Shoichi;
    • Narita, Ichiei
    Publication type:
    Article
    32

    Erratum to: Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial).

    Published in:
    2018
    By:
    • Kato, Hideki;
    • Nangaku, Masaomi;
    • Hirakata, Hideki;
    • Wada, Takashi;
    • Hayashi, Terumasa;
    • Sato, Hiroshi;
    • Yamazaki, Yasushi;
    • Masaki, Takao;
    • Kagimura, Tatsuo;
    • Yamamoto, Hiroyasu;
    • Hase, Hiroki;
    • Kamouchi, Masahiro;
    • Imai, Enyu;
    • Mizuno, Kyoichi;
    • Iwasaki, Manabu;
    • Akizawa, Tadao;
    • Tsubakihara, Yoshiharu;
    • Maruyama, Shoichi;
    • Narita, Ichiei
    Publication type:
    Correction Notice
    33

    Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial).

    Published in:
    Clinical & Experimental Nephrology, 2018, v. 22, n. 1, p. 78, doi. 10.1007/s10157-017-1427-4
    By:
    • Kato, Hideki;
    • Nangaku, Masaomi;
    • Hirakata, Hideki;
    • Wada, Takashi;
    • Hayashi, Terumasa;
    • Sato, Hiroshi;
    • Yamazaki, Yasushi;
    • Masaki, Takao;
    • Kagimura, Tatsuo;
    • Yamamoto, Hiroyasu;
    • Hase, Hiroki;
    • Kamouchi, Masahiro;
    • Imai, Enyu;
    • Mizuno, Kyoichi;
    • Iwasaki, Manabu;
    • Akizawa, Tadao;
    • Tsubakihara, Yoshiharu;
    • Maruyama, Shoichi;
    • Narita, Ichiei
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Determinants of ST-segment elevation myocardial infarction as clinical presentation of acute coronary syndrome.

    Published in:
    Journal of Thrombosis & Thrombolysis, 2021, v. 51, n. 4, p. 1026, doi. 10.1007/s11239-020-02281-7
    By:
    • Kurihara, Osamu;
    • Takano, Masamichi;
    • Kakuta, Tsunekazu;
    • Soeda, Tsunenari;
    • Crea, Filippo;
    • Adriaenssens, Tom;
    • Nef, Holger M.;
    • Boeder, Niklas F.;
    • Yamamoto, Erika;
    • Kim, Hyung Oh;
    • Russo, Michele;
    • McNulty, Iris;
    • Araki, Makoto;
    • Nakajima, Akihiro;
    • Lee, Hang;
    • Mizuno, Kyoichi;
    • Jang, Ik -Kyung
    Publication type:
    Article
    47
    48
    49
    50